Catalyst Funds Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$40.5K	Buy	+28,300	New	+$40.5K	0.01%	386
2024 Q3	–	Sell	-23,228	Closed	-$107K	–	1333
2024 Q2	$107K	Buy	+23,228	New	+$107K	0.03%	275